• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News

Our short URL is biophar.ma

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Pfizer

alopecia areata
Posted inAutoimmune Diseases, Clinical Trials, In the Pipeline, New Drugs, Regulatory

Alopecia Areata Treatment: What Future Holds

August 3, 2022August 4, 2022

What new drugs for hair loss are being developed by the pharmaceutical industry?

psoriasis
Posted inAutoimmune Diseases, New Drugs, Regulatory

Zoryve: New Effective Cream for Psoriasis

August 1, 2022August 4, 2022

Roflumilast will cure plaque psoriasis in half of patients.

multiple-myeloma
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Tecvayli: New Drug for Multiple Myeloma

July 25, 2022August 4, 2022

Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.

Dorzagliatin: Drug That Can “Cure” Diabetes
Posted inClinical Trials, Metabolism

Dorzagliatin: Drug That Can “Cure” Diabetes

June 8, 2022August 4, 2022

Hua Medicine has figured out how to bring type 2 diabetes mellitus into long-term and sustained remission.

Psoriasis.
Posted inAutoimmune Diseases, Clinical Trials

Tycruva: Miracle Pill for Autoimmune Diseases

June 1, 2022August 4, 2022

Deucravacitinib by Bristol-Myers Squibb can help with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, lupus nephritis, and systemic lupus erythematosus.

Posts navigation

1 2 3 4 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2022 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News